MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells

Oncotarget

Volumn 7, Issue 14, 2016, Pages 18085-18094

  Yang, Ting ^a   He, Wanming ^a   Cui, Fei ^a   Xia, Jianling ^a   Zhou, Rui ^a   Wu, Zhenzhen ^a   Zhao, Yang ^a   Shi, Min ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Acetylcholine; Gastric cancer; Invasion; MACC1; Migration

Indexed keywords

ACETYLCHOLINE; ADENYLATE KINASE; FIBRONECTIN; GELATINASE A; GELATINASE B; MESSENGER RNA; MUSCARINIC M3 RECEPTOR; UVOMORULIN; VIMENTIN; BENZOFURAN DERIVATIVE; DARIFENACIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MACC1 PROTEIN, HUMAN; MUSCARINIC RECEPTOR BLOCKING AGENT; PYRROLIDINE DERIVATIVE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GASTRIC CANCER CELL LINE; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MACC1 GENE; METASTASIS POTENTIAL; ONCOGENE; PROTEIN EXPRESSION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ACETYLCHOLINE; AMP-ACTIVATED PROTEIN KINASES; BENZOFURANS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUSCARINIC ANTAGONISTS; NEOPLASM INVASIVENESS; PYRROLIDINES; RECEPTOR, MUSCARINIC M3; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84975519525     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7634     Document Type: Article

References (26)

1. Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ and Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science. 2013; 341:1236361
2. Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, Sandvik AK, Beisvag V, Tomita H, Hara A, Quante M, Li Z, et al. Denervation suppresses gastric tumorigenesis. Science translational medicine. 2014; 6:250ra115
3. Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM and Hondermarck H. Nerve-Cancer Cell Cross-talk:A Novel Promoter of Tumor Progression. Cancer research. 2015; 75:1777-1781
4. Spindel ER. Muscarinic receptor agonists and antagonists:effects on cancer. Handbook of experimental pharmacology. 2012:451-468
5. Shah N, Khurana S, Cheng K and Raufman JP. Muscarinic receptors and ligands in cancer. American journal of physiology Cell physiology. 2009; 296:C221-232
6. Feng Y-J, Zhang B-Y, Yao R-Y and Lu Y. Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells. Hepatobiliary & Pancreatic Diseases International. 2012; 11:418-423
7. Raufman JP, Samimi R, Shah N, Khurana S, Shant J, Drachenberg C, Xie G, Wess J and Cheng K. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer research. 2008; 68:3573-3578
8. Ukegawa JI, Takeuchi Y, Kusayanagi S and Mitamura K. Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells. Journal of cancer research and clinical oncology. 2003; 129:272-278
9. Raufman JP, Cheng K, Saxena N, Chahdi A, Belo A, Khurana S and Xie G. Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells. Biochemical and biophysical research communications. 2011; 415:319-324
10. Xu R, Shang C, Zhao J, Han Y, Liu J, Chen K and Shi W. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway. Tumour biology. 2015; 36:4091-4100
11. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W and Schlag PM. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nature medicine. 2009; 15:59-67
12. Zhang K, Zhang Y, Zhu H, Xue N, Liu J, Shan C and Zhu Q. High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumour biology :the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35:1343-1350
13. Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L, Zhu Q and Chen Y. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Medical oncology. 2014; 31:790
14. Li H, Liao X, Liu Y, Shen Z, Gan X, Li H and Huang Z. The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma. Journal of oral pathology & medicine. 2015
15. Chen L, Wang J, Fu L, Zhang B, Zhang H and Ye B. Prognostic significance of metastasis associated in colon cancer 1 (MACC1) expression in patients with gallbladder cancer. Journal of cancer research and therapeutics. 2014; 10:1052-1056
16. Wang L, Wu Y, Lin L, Liu P, Huang H, Liao W, Zheng D, Zuo Q, Sun L, Huang N, Shi M, Liao Y and Liao W. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. International journal of cancer. 2013; 133:1419-1430
17. Zadra G, Batista JL and Loda M. Dissecting the Dual Role of AMPK in Cancer:From Experimental to Human Studies. Molecular cancer research. 2015; 13:1059-1072
18. Faubert B, Vincent EE, Poffenberger MC and Jones RG. The AMP-activated protein kinase (AMPK) and cancer:many faces of a metabolic regulator. Cancer letters. 2015; 356:165-170
19. Lin L, Huang H, Liao W, Ma H, Liu J, Wang L, Huang N, Liao Y and Liao W. MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 2015; 34:2700-2710
20. Bapat AA, Hostetter G, Von Hoff DD and Han H. Perineural invasion and associated pain in pancreatic cancer. Nature reviews Cancer. 2011; 11:695-707
21. Marchesi F, Piemonti L, Mantovani A and Allavena P. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine & growth factor reviews. 2010; 21:77-82
22. Wang N, Yao M, Xu J, Quan Y, Zhang K, Yang R and Gao WQ. Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK-Mediated Phosphorylation of Akt. Clinical cancer research. 2015; 21:4676-4685
23. Kodaira M, Kajimura M, Takeuchi K, Lin S, Hanai H and Kaneko E. Functional muscarinic m3 receptor expressed in gastric cancer cells stimulates tyrosine phosphorylation and MAP kinase. Journal of gastroenterology. 1999; 34:163-171
24. Wang L, Zhi X, Zhang Q, Wei S, Li Z, Zhou J, Jiang J, Zhu Y, Yang L, Xu H and Xu Z. Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer. Tumour biology. 2015
25. Sun L, Duan J, Jiang Y, Wang L, Huang N, Lin L, Liao Y and Liao W. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer. Cancer letters. 2015; 357:242-253
26. Wang L, Lin L, Chen X, Sun L, Liao Y, Huang N and Liao W. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Oncotarget. 2015; 6:11492-11506. doi:10.18632/oncotarget.3416